GlassScriptPhysician profile
Kristopher F Lay
NPI 1447227830
$2,971.72
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $248 · 2021: $594 · 2022: $1,115 · 2023: $637 · 2024: $23.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $910.85 | 2019-2023 | |
| Alk-Abello, INC | $337.43 | 2019-2023 | Grastek, Odactra, Ragwitek |
| Glaxosmithkline, LLC. | $336.57 | 2021-2023 | Nucala |
| Intersect Ent, INC. | $331.55 | 2019-2022 | |
| Aerin Medical INC. | $235.91 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $228.82 | 2019-2023 | Dupixent |
| Genzyme Corporation | $196.84 | 2021-2023 | |
| Stryker Corporation | $134.84 | 2021-2022 | |
| Abbvie INC. | $99.33 | 2021-2023 | |
| Acclarent, INC | $30.64 | 2023 | Trudi Nav Cable |
| Aimmune Therapeutics, INC. | $26.14 | 2021 | |
| Integra Lifesciences Corporation | $24.63 | 2022 | |
| Olympus America INC. | $23.38 | 2019 | |
| Medtronic, INC. | $23.13 | 2024 | Propel |
| Hikma Pharmaceuticals USA | $18.89 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Lay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.